Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$133M |
| 2 |
AbbVie
ABBV
|
+$110M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$93.9M |
| 4 |
Amazon
AMZN
|
+$91.8M |
| 5 |
Otis Worldwide
OTIS
|
+$84M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$226M |
| 2 |
RTN
Raytheon Company
RTN
|
+$145M |
| 3 |
WBC
WABCO HOLDINGS INC.
WBC
|
+$51.2M |
| 4 |
Newmont
NEM
|
+$50.7M |
| 5 |
Yum! Brands
YUM
|
+$33.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.8% |
| 2 | Healthcare | 15.34% |
| 3 | Consumer Discretionary | 12.54% |
| 4 | Communication Services | 10.48% |
| 5 | Industrials | 8.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
WSFS Financial
WSFS
$4.15B
| $3.3M | ﹤0.01% |
115,040
+18,700
| +19% | +$495K |
|
1402
uniQure
QURE
$3.26B
| $3.29M | ﹤0.01% |
73,100
+5,400
| +8% | +$319K |
|
1403
Opko Health
OPK
$1.04B
| $3.29M | ﹤0.01% |
965,700
+255,700
| +36% | +$573K |
|
|
NGHC
1404
DELISTED
National General Holdings Corp
NGHC
| $3.29M | ﹤0.01% |
152,022
+20,100
| +15% | +$378K |
|
|
FMBI
1405
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $3.28M | ﹤0.01% |
245,400
+32,100
| +15% | +$426K |
|
|
PRNB
1406
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $3.28M | ﹤0.01% |
54,800
+10,300
| +23% | +$636K |
|
1407
MaxLinear
MXL
$6.95B
| $3.27M | ﹤0.01% |
152,573
+20,700
| +16% | +$357K |
|
1408
Boise Cascade
BCC
$2.94B
| $3.27M | ﹤0.01% |
87,000
+11,400
| +15% | +$357K |
|
|
SIX
1409
DELISTED
Six Flags Entertainment Corp.
SIX
| $3.27M | ﹤0.01% |
170,100
+22,600
| +15% | +$449K |
|
1410
Sally Beauty Holdings
SBH
$1.55B
| $3.27M | ﹤0.01% |
260,700
+35,100
| +16% | +$384K |
|
1411
Worthington Enterprises
WOR
$2.78B
| $3.27M | ﹤0.01% |
142,087
+18,977
| +15% | +$339K |
|
1412
Adient
ADNT
$1.44B
| $3.27M | ﹤0.01% |
198,898
+26,400
| +15% | +$401K |
|
1413
Innovative Industrial Properties
IIPR
$1.67B
| $3.26M | ﹤0.01% |
37,000
+4,800
| +15% | +$391K |
|
1414
Medifast
MED
$130M
| $3.25M | ﹤0.01% |
23,400
+700
| +3% | +$64.3K |
|
1415
Palomar
PLMR
$3.37B
| $3.24M | ﹤0.01% |
37,800
+5,000
| +15% | +$332K |
|
|
BECN
1416
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $3.24M | ﹤0.01% |
122,900
-10,100
| -8% | -$226K |
|
|
FIT
1417
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $3.23M | ﹤0.01% |
500,400
+55,300
| +12% | +$361K |
|
1418
Pediatrix Medical
MD
$2.15B
| $3.22M | ﹤0.01% |
188,100
+24,600
| +15% | +$365K |
|
1419
Urban Edge Properties
UE
$2.78B
| $3.22M | ﹤0.01% |
271,009
+35,900
| +15% | +$360K |
|
|
ARI
1420
Apollo Commercial Real Estate
ARI
$885M
| $3.2M | ﹤0.01% |
326,639
+43,700
| +15% | +$371K |
|
1421
The GEO Group
GEO
$4B
| $3.2M | ﹤0.01% |
270,600
+35,400
| +15% | +$432K |
|
1422
CareDx
CDNA
$2.45B
| $3.19M | ﹤0.01% |
90,000
+15,900
| +21% | +$452K |
|
|
AAT
1423
American Assets Trust
AAT
$1.39B
| $3.17M | ﹤0.01% |
114,000
+15,200
| +15% | +$416K |
|
1424
Appian
APPN
$2.49B
| $3.16M | ﹤0.01% |
61,700
+11,900
| +24% | +$581K |
|
1425
Mueller Water Products
MWA
$4.09B
| $3.16M | ﹤0.01% |
335,100
+29,400
| +10% | +$263K |
|
Similar funds
Swiss National Bank's Q2 2020 Portfolio in Review
As of Q2 2020, Swiss National Bank held 2,599 positions worth $118B, up 26% from $94.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Swiss National Bank's Q2 2020 filing shows 119 new, 2,134 increased, 181 reduced and 161 closed positions. Its largest new stake was Otis Worldwide: 1,621,054 shares worth $92.2M. The largest sale was Allergan plc, an estimated $226M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q2 2020 buy was Otis Worldwide: 1,621,054 shares worth $92.2M.
- Swiss National Bank added most to Alibaba in Q2 2020, an estimated $133M increase.
- Swiss National Bank's biggest Q2 2020 reduction was Newmont, cutting an estimated $50.7M.
- Swiss National Bank fully exited Allergan plc in Q2 2020, selling an estimated $226M.
- Swiss National Bank's ten largest holdings make up 24% of its $118B portfolio in Q2 2020.
- Swiss National Bank opened 119 new positions and closed 161 in Q2 2020.
- Swiss National Bank's portfolio value rose 26% quarter-over-quarter to $118B.
Based on Swiss National Bank's 13F filing for Q2 2020, filed 5 Aug 2020.